DV
Dividend Vision

OCUL — Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. (OCUL)

Total return is -23.7% over the past 12.1 years, 403.9 points behind SPY at 380.2%. Its deepest 1-year drawdown was 57.3%.

OCUL is a single-stock equity position in Ocular Therapeutix, Inc., a biopharmaceutical company focused on ophthalmic therapeutics. The stock currently does not pay dividends and carries no distribution frequency, making it unsuitable for income-focused investors seeking regular dividend payments. This holding appeals primarily to growth-oriented investors interested in the biotechnology sector rather than those pursuing dividend income strategies.

OCUL key facts

Asset type
Stock
Asset class
Equity
Inception date
07/25/2014
Distribution frequency
None
Last close
$10.04
Market cap
$2,204,943,360
Average volume
1631500.0
Beta
0.935
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.40